Discovery of Sch 900188: A Potent Hepatitis C Virus Ns5B Polymerase Inhibitor Prodrug as a Development Candidate
Chen, K.X., Venkatraman, S., Anilkumar, G.N., Zeng, Q., Lesburg, C.A., Vibulbhan, B., Velazquez, F., Chan, T.-Y., Bennett, F., Jiang, Y., Pinto, P., Huang, Y., Selyutin, O., Agrawal, S., Huang, H.-C., Li, C., Cheng, K.-C., Shih, N.-Y., Kozlowski, J.A., Rosenblum, S.B., Njoroge, F.G.(2014) ACS Med Chem Lett 5: 244
- PubMed: 24900812 
- DOI: 10.1021/ml400192w
- Primary Citation of Related Structures:  
2YOJ - PubMed Abstract: 
Starting from indole-based hepatitis C virus (HCV) NS5B polymerase inhibitor lead compound 1, structure modifications were performed at multiple indole substituents to improve potency and pharmacokinetic (PK) properties. Bicyclic quinazolinone was found to be the best substituent at indole nitrogen, while 4,5-furanylindole was identified as the best core ...